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Abstract. The cycle of nucleotide exchange and hy- 
drolysis by a  small GTP-binding  protein,  ADP- 
ribosylation factor (ARF), helps to provide vectorial- 
ity to vesicle transport.  Coat assembly is triggered 
when ARF binds GTP,  initiating  transport  vesicle bud- 
ding,  and coat disassembly is triggered  when ARF 
hydrolyzes GTP,  allowing the uncoated vesicle to fuse. 
T 
HE  secretory pathway consists of sequential  vesicle 
budding and fusion events that result in the vectorial 
movement of cargo proteins through a series of mem- 
brane bound compartments  until  their  final destination  is 
reached (Palade,  1975). It is now known that transport re- 
quires  components  from the cytosol (Rothman  and  Orci, 
1992;  Pryer  et al.,  1992),  raising  fundamental  questions 
concerning vectoriality such as how the assembly and disas- 
sembly of vesicle coats is spatially controlled. 
The budding of Golgi-derived,  COP-coated vesicles has 
been reconstituted in vitro, and in addition to Golgi mem- 
branes, requires only two coat proteins, coatomer and ADP- 
ribosylation factor (ARF) l (Waters et al.,  1991;  Serafini et 
al.,  1991a),  from cytosol (Orci et al.,  1993a).  Coatomer 
binding to Golgi membranes requires prior binding of ARF 
(Donaldson et al.,  1992b; Palmer et al.,  1993). The Golgi 
cisternal membranes remain flat when only ARF has bound, 
but when coatomer binds, coated regions of membrane are 
deformed into the shape of a vesicle (Orci et al.,  1993a). 
ARF can only bind Golgi membranes in its N-myristoylated 
(mARF)  and GTP-bound  form (Donaldson  et al.,  1992b; 
Helms and Rothman, 1992; Haun et al., 1993; Helms et al., 
1993), and this activated ARF is generated when cytosolic 
mARF[GDP] encounters a Golgi-bound nucleotide exchange 
factor in the presence of free GTP. Brefeldin A (BFA) blocks 
nucleotide exchange (Donaldson et al.,  1992a;  Helms and 
Rothman,  1992), thereby preventing ARF binding and sub- 
sequent ARF-dependent assembly of coated vesicles (Orci et 
al.,  1991).  This explains why BFA blocks secretion (Klaus- 
ner et al.,  1992) and underscores the physiological signifi- 
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cance of the coated vesicle pathway, whose in vivo impor- 
tance  is  also  made  clear  by the  fact that  both  ARF and 
Sec21p, the 7-COP homolog, are essential in yeast (Stearns 
et al.,  1990; Stenbeck et al.,  1992; Hosobuchi et al.,  1992) 
and  that  /3-COP  antibodies  block transport  from  the  ER 
(Pepperkok et al.,  1993; Peter et al.,  1993). ARF binds to 
the lipid bilayer and additionally to distinct receptor sites in 
the  Golgi membrane.  The latter  are  likely to be relevant 
to coated vesicle assembly because ARF-dependent coatomer 
binding  is  a  saturable  process  (Donaldson  et al.,  1992b; 
Palmer et al.,  1993). 
In this report, we test the hypothesis that uncoating occurs 
when ARF in coated vesicles hydrolyze their bound GTP. 
We employ a mutant crippled in GTP hydrolysis according 
to  the  following  rationale.  GTP'yS  inhibits  intercisternal 
transport reconstituted in a cell-free system of Golgi mem- 
branes  incubated with cytosol and ATP,  and concurrently 
COP-coated vesicles accumulate (Melanfon et al., 1987). A 
cytosolic component  needed  for  this  inhibition  has  been 
purified and found to be ARF (Taylor et al., 1992), and ARF 
is now known to be a  subunit of the coat (Serafini et al., 
1991a)  required  for  vesicle  assembly  (Donaldson  et  al., 
1992a; Palmer et al., 1993; Orci et al., 1993a). The simplest 
explanation of these facts would be that GTP hydrolysis by 
ARF, which cannot occur when ARF is bound to GTP3,S, 
triggers coat disassembly. This mutant is equivalent to acti- 
vated Ras mutants  which cause oncogenic transformation; 
activated ARF stimulates the formation of COP-coated vesi- 
cles in the context of Golgi transport. 
Materials and Methods 
Preparation of  ARF 
A DNA sequence corresponding to human ARF1 was synthesized by PCR 
and ligated to the expression vector pETlld between the NcoI and BamHI 
sites (Novagen, Madison, WI; Dubendorff and Studier, 1991). The Q71L 
mutation was introduced into the wild-type sequence by site-directed muta- 
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quenase 2.0 (Un. States Biochemical, Cleveland, OH). Myristoylated pro- 
teins were produced in E. coli strain BL2 I(DE3) (Novagen) by coexpressing 
yeast N-myristoyltransferase  (pBB131 in Duronio et al., 1990) and pETI Id- 
ARF and purified by DEAE-Sephacel  (Pharmacia LKB Biotechnology, Pis- 
cataway, N  J) and Ultrogel  AcA54 (Sepracor,  Marlborough, MA) chroma- 
tographies (Weiss et al., 1989; Helms et al., 1993). Protein concentrations 
were determined using the bicinchoninic acid assay and a standard curve 
of varying amounts  of BSA (Pierce, Rockford,  IL). 
Coatomer Binding Assay 
CHO Golgi (86 #g/ml protein) was incubated with 28 mM Hepes-KOH (pH 
7.2),  20 mM NaCI,  35  mM KC1, 2.5  mM Mg(OAc)2, 20 /zM guanine 
nucleotide, 0.2 M sucrose,  107 #g/ml bovine liver coatomer,  and 100/~g/ml 
recombinant mARF at 37°C for 10 min in a volume of 50/~1 (Palmer et al., 
1993).  Golgi membranes were pelleted through a  15%  (wt/wt)  sucrose 
cushion, protein was fractiouated on a 12% SDS-PAGE gel under reducing 
conditions (Laemmli, 1970), and coatomer was detected by Western blot- 
ting (50 ng/ml of affinity purified antiserum to e-COP, the 36-kD coatomer 
subunit)  with ECL reagent (Amersham Corp., Arlington Heights,  IL). 
Nucleotide Exchange Assay 
Recombinant mARF (78/zg/ml) was incubated with 25 mM Hepes-KOH 
(pH 7.2),  20 mM KCI,  2.5 mM Mg(OAc)2, 0.5  mM sodium  pyrophos- 
phate,  1.6 mg/ml ovalbumin, CHO Golgi (60/~g/ml protein), 5/~M [3,-32P] 
GTP (18,400 cpm/pmol, Amersham), and 0.2 M sucrose at 37°C for 15 min 
in a volume of 0.1 ml (Helms et al.,  1993). 
In Vitro Transport Assay 
Cis- to medial-Golgi transport of vesicular stomatitis virus G protein (Balch 
et al., 1984; Balch and Rothman, 1985) was assayed in reactions containing 
25  mM  Hepes-KOH  (pH  7.2),  10  mM  NaC1, 21  mM  KC1, 2.5  mM 
Mg(OAc)2, 3.1  mg/ml bovine brain cytosolic proteins, 50 #M ATE 250 
#M UTP, 5 mM creatine phosphate, 8 IU/ml creatine phosphate kinase, 5 
/~l acceptor CHO Golgi, 5/~l donor CHO Golgi, 0.2 M sucrose,  and 0.4 
#M [3H] UDP-GlcNAc  (0.5 ttCi, Da Pont, New England Nuclear, Boston, 
MA) in a total volume of 50/zl. After incubation at 37*C for 1 h, VSV-G 
protein  was  immunoprecipitated  and  counted.  Brefeldin  A  was  from 
GIBCO BRL (Gaithersburg, MD) and GTP'tS was from Sigma Chem. Co. 
(St.  Louis,  MO). 
Assembly of Coated Vesicles on the Golgi 
CHO Golgi (86/zg/ml protein) was incubated with 25 mM Hepes-KOH (pH 
7.2),  10 mM NaCI,  18 mM KCI, 2.5 mM Mg(OAc)2,  1 mg/ml soy bean 
trypsin inhibitor, 37.5/~g/ml bovine liver coatomer, 52 #g/ml recombinant 
mARE either 20/~M GTP'yS or 1 mM GTP,  andO.2 M sucrose at 37°C 
for 10 min in a volume of 0.5 ml (Orei et al.,  1993a). 
Electron Microscopy and Quantitation 
Membranes were  collected by centrifugation for  15 min in a horizontal 
microfuge and supernatants were aspirated.  Pellets were fixed overnight in 
the coldroom with 1% glutaraldehyde  (EM grade,  Polysciences,  Warring- 
ton, PA) and 50 mM phosphate buffer (pH 7.0), contrasted with tannic acid, 
embedded in Epon, and quantitated (Orci et al., 1986, 1991). All morpho- 
logical measurements were done in a double-blind fashion using a code that 
was not broken until quantitation was completed. 
Results 
An ARF  Mutant That Does Not Hydrolyze GTP 
We  have  focused on  the  ARF1  protein,  which  mediates 
coatomer  binding  and  coated  vesicle  assembly  in  vitro 
(Donaldson et al.,  1992a;  Palmer et al.,  1993; Orci et al., 
1993a) and is sensitive to BFA inhibition (Donaldson et al., 
1992a;  Helms and Rothman,  1992).  As a  member of the 
small GTP-binding  protein  family (Bourne  et al.,  1991), 
ARF1  contains consensus GTP-binding sites in its protein 
sequence. Intrinsic hydrolysis of GTP by ARF1 is not detect- 
able (Kahn and Gilman,  1986) but we assume that bound 
GTP is hydrolyzed in the appropriate biological context. In 
analogy to the Ras-Q61L mutation which inhibits GTP hy- 
drolysis but not GTP binding (Der et al., 1986), we mutated 
the corresponding codon 71  Gin to Leu. Soluble mARF1 
(Fig.  1,  lane /)  and mARF1-Q71L  (lane 2) proteins  were 
purified from E. coli coexpressing N-myristoyltransferase. 
Each ARF protein was isolated with stoichiometric amounts 
of bound GDP as determined by anion exchange chromatog- 
raphy (data not shown). 
Purified mARF1-Q'/1L  is  native because  it satisfies  the 
ARF requirement for coatomer binding to Golgi membranes 
(Fig. 1, lanes 3-5) and this process requires GTE The bind- 
ing of coatomer to Golgi membranes mediated by wild-type 
mARF1  is enhanced by nonhydrolyzable GTP-yS as com- 
pared to GTP (cf. lanes 7and 8). However, the same amount 
of coatomer is bound via mutant mARF1-Q71L regardless of 
whether GTP or nonhydrolyzable GTP3,S is used (cf. lanes 
4 and 5). This strongly suggests that mARF1-Q'/1L binds to 
membranes but does not hydrolyze  GTP, in contrast to wild- 
type mARF1. 
To directly examine membrane-dependent GTP hydrolysis 
by wild-type and mutant ARF proteins,  [3,-32P] GTP was 
incubated in a nucleotide exchange reaction with mARF and 
Golgi, membranes and bound proteins were pelleted through 
a  sucrose  cushion,  and  bound  nucleotide  retained  on 
nitrocellulose filters was counted (Fig.  2).  In accordance 
Figure 1. mARFI-~I1L promotes coatomer binding to Golgi mem- 
branes.  1/zg of mARF1 (lane/) or mARF1-Q'/1L (lane 2) was run 
on a  15%  PAGE-SDS gel under reducing conditions and stained 
with Coomassie  blue  (Laemmli,  1970).  Molecular weight  stan- 
dards are shown.  Coatomer binding assays (Palmer et al.,  1993) 
included either recombinant mARFI-Q71L (lanes 3-5) or mARF1 
(lanes 6-8). No additional guanine nucleotide (lanes 3 and 6), 20 
/zM GTP (lanes 4 and 7), or 20/zM GTP'rS (lanes 5  and 8) was 
included in the binding reaction, e-COP bound to Golgi membranes 
was detected by Western blotting. 
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Golgi-catalyzed nucleotide exchange of ARF using [3,-32P] GTP 
was performed as described in Materials and Methods (Helms et 
al., 1993). Golgi membranes and bound ARF protein were pelleted 
through a cushion of 25 % (wt/vol) sucrose in 25 mM Hepes-KOH 
(pH Z2), 20 mM KCI, and 2.5 rnM Mg(OAc)2; solubilized with 
0.5% Triton X-100 in PBS; and radioactivity bound to protein was 
determined by the nitrocellulose filter trapping assay (Northup et 
al., 1982). 
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Figure 3.  mARFI-Q71L inhibits Golgi protein transport. Recom- 
binant ARF (  ARF1-QT1L,filled squares; mARF1, open circles; and 
mARF1-QT1L, open squares) was titrated into transport assays 
(Balch et al., 1984; Balch and Rothman, 1985). All reactions in- 
cluded the same concentrations of salts. 
with the previous observation that mARF1 quickly hydro- 
lyzes GTP after membrane-cataiyzed nucleotide exchange 
(Helms  et  al.,  1993),  incubating wild-type mARF1  and 
Golgi together (column 3) results in no additional counts 
over Golgi or mARF1 alone (columns 1 and 2) because when 
the GTP is hydrolyzed, the 3"_3:p label is released. A con- 
trol with [ot-32P] GTP demonstrated that the derived GDP 
remains bound to mARF1  (data not shown).  In contrast, 
mARF1-Q71L retains the 3' phosphate of GTP (cf. column 5 
with the sum of columns 1 and 4). Altogether, these experi- 
ments show that mARF1-Q71L binds GTP but hydrolyzes it 
more slowly than does wild-type protein. 
The ARF GTPase Mutant Assembles Coated Vesicles 
and Inhibits Cell-Free Transport 
A  clear prediction from the above is that mutant mARF1- 
Q71L should retain the capacity to assemble coated vesicles. 
Wild-type or mutant mARF1 proteins were incubated with 
CHO  Golgi  membranes,  coatomer,  and  either  GTP  or 
GTP3"S; the production of COP-coated vesicles was assayed 
by quantitative electron microscopy (Table I). Coated buds 
and coated vesicles were formed with mARF1-Q71L and ei- 
ther GTP or GTP3'S. 
mARF1-Q71L  is a  potent inhibitor in the cis to medial 
Golgi transport assay (Fig. 3). Inhibition by the GTP hydrol- 
ysis  mutant means  that  it  is  dominant over  endogenous 
mARF in bovine brain cytosol, as would be predicted if the 
mutant substitutes functionally for wild-type protein and al- 
lows  the transport pathway to proceed up to the point at 
which GTP hydrolysis is required. The concentration of mu- 
tant mARFI that inhibits the transport assay by 50%  (IC50 
of 2/~g/ml) is lower than that of ARF purified by Taylor et 
ai. (1992) (ICs0 of 12-32 #g/ml) and may reflect the differ- 
ence in transport conditions used in the two assays. W'fld- 
type mARFI does not inhibit in the absence of GTP3'S over 
the range of concentrations used and N-myristoylation  of  the 
GTPase mutant is required for inhibitory activity. Transport 
intermediates resistant to mARF1-Q71L are generated at the 
same  rate  as  GTP3'S-resistant  intermediates  (Fig.  4),  as 
would be expected if inhibition by GTP3"S and mARF1-Q71L 
affect the same step in the transport reaction. 
To confirm that inhibition by mARFI-Q'/1L requires ex- 
change of GTP for bound GDP, we used BFA. Addition of 
mARFI-Q71L after BFA does not completely inhibit VSV-G 
protein glycosylation (Fig. 5, column 3) and implies that the 
mutant must be activated by nucleotide exchange to inhibit 
transport. Adding BFA after mARF1-Q71L does not reverse 
Table I.  Wild-Type  mARF1  and Mutant mARF1-Q71L Initiate  Coat Assembly 
C 
A  B  Percentage  of buds 
Uncoated vesicles  Coated buds and coated  or vesicles with 
(no. per ten  z)  vesicles (no. per p.m  z)  a complete coat 
(1) mARF1 +GTP3,S 
(2) mARF1-Q71L +GTP 
(3) mARF1-Q71L+GTP3,S 
0.2  +  0.2  55.4  +  2.5  100% 
ND  41.3  +  3.3  100 
ND  71.2  +  3.8  100 
Coated buds and coated vesicles were assembled on Golgi membranes in cytosol-free reactions containing guanine nucleotide, recombinant mARF, and coatomer 
(see Materials and Methods).  Values are means  5:  standard error based on analyzing ten Golgi areas for each pellet. ND, none detected. 
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Figure 4.  mARF1-Q71L and GTP3,S inhibit  at the same stage  of 
Golgi protein transport. A standard time course (filled squares) was 
generated by stopping transport assays at different times At (Melan- 
~on et al.,  1987).  GTPTS-resistant  transport intermediates  (filled 
circles) were assayed by adding GTP3,S to 20/~M at the indicated 
times and incubated at 370C for a total of 2 h. Intermediates  resis- 
tant to 52/~g/ml mARF1-Q71L (open squares) were assayed in the 
same  manner. 
which hydrolysis of GTP by ARF is first required,  and also 
accumulate at earlier  stages. 
Addition of recombinant wild-type mARF1 (Fig.  6 a  and 
Table II, row 3) or coatomer (row 4) to the reaction each in- 
creases the total number of vesicles in a cell-free transport 
reaction (ef. row 1), both with and without the characteristic 
electron-dense coat. However, the GTPase mutant of ARE 
mARFI-QT1L (Fig.  6  b  and Table II, row 5) markedly in- 
creases the number of coated vesicles about 3.5-fold relative 
to the control with wild-type mARF1 and correspondingly 
reduces the level of their uncoated products,  similar to the 
effect of GTP3,S  (row 2).  An increase of ,~l.3-fold in the 
number of coated buds is also observed. 
Discussion 
The discovery that the small GTP-binding protein ARF is a 
inhibition (column 4), as is also the case when adding BFA 
after GTP3,S (Orci et al.,  1991). 
Inability to Hydrolyze GTP Prevents Uncoating 
Because the GTPase mutant inhibits transport (Fig.  3) but 
does not inhibit the production of coated vesicles (Table I), 
the simplest possibility would be that mARF1-Q71L blocks 
transport by preventing the consumption of coated transport 
vesicle  intermediates.  If so,  most  transport  intermediates 
should  accumulate  at  the  specific  stage  of the  reaction  at 
Figure 5. mARFI-Q71L  inhibition is blocked by brefeldin A. Trans- 
port was assayed in 50 #1 reactions with 200 #M BFA (column 1 ), 
5.2/~g mARF1-Q71L (column 2), 200/~M BFA followed by 5.2/~g 
mARF1-Q71L 10 min later (column 3), or 5.2 #g mARF1-Q71L fol- 
lowed by 200 ~M BFA 10 min later (column 4). All reactions  were 
incubated at 370C for a total of 70 min and included  1/,1 methanol, 
the solvent of BFA. 
Figure 6. Electron microscopy of Golgi-derived  vesicles.  (a) Stan- 
dard transport plus wild-type mARFI or (b) standard transport plus 
mutant mARF1-Q71L. The striking difference is that most vesicles 
are uncoated in a (arrowheads), while they remain coated in b (ar- 
rows). Some remnants of coat structure appear on the periphery of 
uncoated vesicles in a. Coated buds (cb) are present in both condi- 
tions,  c, cisternal  elements.  See  Table II for quantitation  of the 
respective  numbers of vesicles  and buds.  CHO Golgi membranes 
(86/~g/ml protein in 0.2 M sucrose)  were incubated  in transport 
reactions  including  19 t~M palmitoyl CoA and 52/~g/ml recom- 
binant mARF (see Materials  and Methods)  in a total volume of 0.5 
ml at 37°C for 10 min.  x59,000, magnification. 
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D 
A  B  C  Percentage of buds 
Uncoated  vesicles  Coated buds  Coated vesicles  or vesicles with 
(no.  per lard)  (no. per ton")  (no. per/~nf)  a complete coat 
(1) Standard transport  2.4 5- 0.9  5.2 5- 1.6  2.0 + 0.8  75% 
(2) Standard transport 
+  GTP3,S  ND  14.6 5- 2.6  9.5 +  1.5  100 
(3) Standard transport 
+  mARF1  11.0 5- 1.6  9.0 5- 1.6  2.2 5- 0.8  50 
(4) Standard transport 
+  coatomer  5.5 5- 2.1  9.1  5- 0.7  2.5 5- 0.9  68 
(5) Standard transport 
+  rnARFI-Q71L  0.8 ± 0.4  11.8 5- 1.9  7.8 5-  1.0  96 
CHO Golgi membranes were incubated in transport reactions containing 19 t~M GTP3,S, 52 ,ag/nd wild-type mARF1 or mutant mARFI-Q71L, or 24 #g/ml bovine 
liver coatomer as described in Fig. 6.  Values are means +  standard error based on analyzing ten Goigi areas for each pellet. ND, none detected. 
subunit of the coat (Serafini et al., 1991a), together with the 
observation that GTP~/S blocks transport and accumulates 
coated vesicles (Melanqon et al., 1987),  led to the specific 
hypothesis that GTP hydrolysis by ARF triggers vesicle un- 
coating. Evidence that ARF plays a critical role in the assem- 
bly of the coat has since accumulated (Donaldson et al., 
1992a,b; Kahn et al., 1992; Taylor et al., 1992; Helms and 
Rothman,  1992;  Haun et al.,  1993;  Hells et al.,  1993; 
Palmer et al., 1993; Orci et al., 1993a), and we now provide 
a  direct test of this hypothesis by employing a  mutant of 
ARF1. This GTPase mutant dominantly interferes with cell- 
free transport and concomitantly accumulates coated trans- 
port vesicles at the expense of their uncoated products. This 
affords strong confirmation of the role coated vesicles play 
as transport intermediates in the cell-free system, and in par- 
ticular provides genetic proof that the hydrolysis of GTP by 
ARF is needed for removal of the coat and to allow fusion 
of  the enclosed vesicle (as evidenced by the lack of  glycosyla- 
tion of VSV-G protein when the GTPase mutant is used). 
This suggests that in addition to forming the vesicle (Orci et 
al., 1993a,b), the coat plays an important role in preventing 
inappropriate fusion events. 
Indeed, in work to be described elsewhere (Elazar, Z., L. 
Orci, M. Amherdt, G. Tanigawa, and J. E. Rothman, manu- 
script in preparation), we will report that removal of either 
ARF or coatomer from cell-free transport reactions halts 
vesicular transport but simultaneously unleashes a direct fu- 
sion between Golgi stacks of the kind associated with BFA 
(Orci et al.,  1991; Klausner et al.,  1992).  This essentially 
nonphysiological fusion reaction, induced by removing com- 
ponents that are normally present, also explains why sub- 
stantially removing ARF does not halt glycosylation  of  VSV-G 
protein in cell-free assays (Taylor et al., 1992). A signal can 
be produced in these assays when transport is due either to 
COP-coated vesicles generated in crude cytosol or to direct 
fusion, uncoupled from budding, with cytosol depleted of 
coat proteins. 
Based on the physical properties of ARF and the require- 
ment for ARF in binding coatomer to membranes, a simple 
mechanism for uncoating can be proposed (Fig. 7), essen- 
tially coating in reverse. The conformational switch that all 
GTP-binding proteins  undergo  when alternating between 
GDP- and GTP-bound forms (Bourne et al., 1991; Witting- 
hofer,  1992)  is used by mARF to control exposure of its 
N-myristoyl group:  mARF[GTP],  but not mARF[GDP], 
binds to artificial phospholipid bilayers (Kahn, 1991; Walker 
et al., 1992) and the lipid bilayer of Golgi membranes (Haun 
et al.,  1993;  Helms et al.,  1993) and binding requires the 
myristoyl modification. Switching into the bilayer-binding 
GTP form is required for mARF to hind to specific sites in 
Golgi membranes ('~ARF  receptors  ~) and to form complexes 
with coatomer before coated vesicle budding (Donaldson et 
al., 1992a,b; Hells and Rothman, 1992; Haun et al., 1993; 
Helms et al., 1993; Palmer et al., 1993; Orci et al., 1993a). 
Given these properties,  it is predictable that when ARF 
hydrolyzes its GTP, the protein will switch back to the GDP 
conformation, "retract" its fatty acid, and dissociate from the 
membrane of the coated vesicle. Because coatomer binding 
to membranes is ARF-dependent (Donaldson et al., 1992b; 
Palmer  et  al.,  1993),  coatomer release  into  the  cytosol 
would be expected to follow dissociation of ARE Consistent 
with this, neither ARF nor coatomer is present in uncoated 
vesicles that accumulate when the fusion protein NSF is in- 
activated, as judged by electron microscopic immunocyto- 
chemistry (Serafini et al., 1991a,b).  While our experiments 
show that GTP hydrolysis by ARF is necessary for uncoat- 
ing, they do not formally prove that the relevant ARF mole- 
cules are those actually in the coated vesicles. The fact that 
the N-myristoyl group is needed for the GTPase mutant of 
ARF to block transport implies that the inhibitory ARF pro- 
tein must be membrane bound, consistent with the idea that 
mARF1-Q71L inhibits by substituting for endogenous, wild- 
type mARF1 in forming coated vesicles. 
Our present observations, together with earlier ones, pro- 
vide new insights into the way in which this small GTP- 
binding protein is used to provide vectoriality in vesicle 
transport (Fig. 7).  Coat assembly is initiated at the donor 
membrane where ARF can productively interact with its 
receptor;  coat  disassembly  (required  to  initiate  fusion) 
results when ARF is triggered to hydrolyze its bound GTP. 
Is uncoating (e.g., hydrolysis of ARF-bound GTP) triggered 
before or after contact with the target membrane? When 
transport is blocked by GTP3,S, coated vesicles accumulate 
bound to Golgi membranes and to each other but not to other 
membranes (plasma membranes, endosomes, etc.) present 
in Golgi membrane fractions (Melangon et al.,  1987; Orci 
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Figure 7. Diagram of vectori- 
ality by GTP exchange and hy- 
drolysis  of ARE  Nucleotide 
exchange of mARF (circle) at 
the donor membrane triggers 
binding to the Golgi; brefeldin 
A blocks this process (Donald- 
son et al.,  1992a; Helms and 
Rothman,  1992)  (step  1). 
Binding of mARF to the do- 
nor membrane enables  coat- 
omer (rectangles) to bind to the 
Golgi and bud off coated vesi- 
cles (Donaldson et al., 1992b; 
Palmer et al., 1993) (step 2). 
GTP hydrolysis by mARF in 
the coat at the acceptor mem- 
brane (or possibly before vesi- 
cle  attachment)  triggers  un- 
coating to enable  subsequent 
fusion of the vesicle and Golgi 
(step 3). 
et al., 1989). This reveals that at least to some extent coated 
vesicles can select their target while the coat is still intact. 
Many  of  these  accumulated  coated  vesicles  must  have 
departed from donor Golgi and then become associated with 
acceptor Golgi because the vesicles contain VSV-G protein 
but are juxtaposed to Golgi stacks virtually free of VSV-G 
protein (derived from acceptor). Thus, the simplest interpre- 
tation is that uncoating occurs after the coated vesicle ini- 
tially binds to the target membrane, and when GTP cannot 
be hydrolyzed, the reaction proceeds no further.  However, 
we can not rule out that docking occurs before GTP is hydro- 
lyzed. Also, the fact that coated vesicles can dock with Golgi 
selectively does not rule out that additional, higher affinity 
docking interactions (S611ner et al.,  1993) may occur after 
uncoating takes place.  That the same species of ARF can 
bind  coatomer (COP-coated vesicles,  Orci et al.,  1993a) 
and Golgi-specific adaptor AP-1  (clathrin-coated  vesicles, 
Stamnes  and  Rothman,  1993)  to Golgi membranes illus- 
trates that ARF must decode rather than store vectorial in- 
formation. This model differs from that proposed by Bourne 
(1988) which envisioned that small GTP-binding proteins at- 
tach vesicles to targets and provide specificity to this pro- 
cess. It now appears that the best candidate for encoding tar- 
geting specificity is the SNARE family (S611ner et al., 1993; 
Brennwald and Novick,  1993;  Dunn et al.,  1993). 
ARF interacts with Golgi membranes in two distinct ways 
(Helms et al.,  1993) and both events require that ARF be 
myristoylated and be activated by nucleotide exchange to the 
GTP form. The loosely bound population of mARF interacts 
directly with the lipid bilayer via the fatty acid, as it is ex- 
tracted by phospholipid bilayer vesicles, and as it does not 
exhibit saturable binding with respect to ARF concentration. 
The tightly bound population of mARF is resistant to lipo- 
somes and is saturable with respect to ARF concentration, 
thereby operationally defining "ARF receptor" sites.  Thus the 
product of nucleotide exchange, activated ARF, can be trans- 
ferred between membranes in vitro. ,If this occurs in vivo, 
then nucleotide exchange enzymes need not be located spe- 
cifically to the donor compartments. It is thus an open ques- 
tion as to whether compartmentally specific ARF receptors, 
exchange enzymes, or possibly both define the donor site. 
A considerable body of genetic and biochemical evidence 
has established that small GTP-binding proteins of the Rab 
family are needed for unknown reasons in many transport or 
fusion  processes  in  living  cells  and  in  cell-free  systems 
(Pfeffer, 1992; Sztul et al., 1992). In fact, antibodies to Rabl 
(Plutner et al., 1991) inhibit Golgi transport and this suggests 
that at least one other small GTP-binding protein is required. 
Perhaps these proteins resist GTP-yS because they act in their 
GTP-bound forms,  or because an adequate  supply of the 
GTP-bound form is present in the crude extracts employed 
in these assays. 
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